BOTOX Side Effects

7011281-2 | Anxiety, Hypoaesthesia Facial, Panic Attack, Sudden Hearing Loss
on Sep 22, 2010 Female patient from UNITED STATES , weighting 127.0 lb, was diagnosed with skin wrinkling and was treated with Botox (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), hypoaesthesia facial, panic attack, sudden hearing loss. Botox dosage: Every 3-4 Months Im.

6994359-9 | Aspiration, Dysphagia
Patient was taking Botox (View Usage). Patient had the following side effects: aspiration, dysphagia on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , 51 years of age, was diagnosed with oromandibular dystonia and. Botox dosage: 12.5 Units, Single.

6992449-8 | Dry Eye, Dry Mouth, Dysphagia, Hypoaesthesia Oral, Paraesthesia, Rash, Swollen Tongue, Tremor
Adverse event was reported on Sep 16, 2010 by a Female patient taking Botox (View Usage) (Dosage: 20 Units, Single) was diagnosed with skin wrinkling and. Location: AUSTRALIA , 42 years of age, After Botox was administered, patient had the following side effects: dry eye, dry mouth, dysphagia, hypoaesthesia oral, paraesthesia, rash (What is rash?), swollen tongue, tremor. During the same period patient was treated with ZANTAC (2 Daily) (View Zantac Review and Zantac Label ), CLARATYNE (View Claratyne Review and Claratyne Label ), PHENERGAN (Unk) (View Phenergan Review and Phenergan Label ). Patient was hospitalized.

6990853-5 | Alopecia, Back Pain, Burning Sensation, Bursitis, Cognitive Disorder, Confusional State, Dementia, Diarrhoea, Dysphagia
on Sep 07, 2010 Female patient from UNITED STATES , 56 years of age, weighting 137.0 lb, was diagnosed with torticollis, head titubation, tremor, pain (What is pain?) and was treated with Botox (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, back pain (What is back pain?), burning sensation, bursitis (What is bursitis?), cognitive disorder, confusional state, dementia (What is dementia?), diarrhoea, dysphagia. Botox dosage: 200 Units, Single. During the same period patient was treated with MYSOLINE (450 Mg, Unk) (View Mysoline Review and Mysoline Label ), DEPO MEDROL (20 Units, Single) (View Depo-medrol Review and Depo-medrol Label ). Patient was hospitalized and became disabled.


6987393-6 | Stevens-johnson Syndrome
on Sep 13, 2010 Male patient from UNITED STATES , 74 years of age, weighting 136.0 lb, was diagnosed with torticollis and was treated with Botox (View Usage). Patient had the following side effects: stevens-johnson syndrome. Botox dosage: 100 Units, Single.

6987382-1 | Angioedema, Urticaria
Patient was taking Botox (View Usage). After Botox was administered, patient had the following side effects: angioedema, urticaria on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , 74 years of age, was diagnosed with torticollis and. Botox dosage: 100 Units, Single. During the same period patient was treated with BENICAR (Unk) (View Benicar Review and Benicar Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6986000-6 | Burning Sensation, Decreased Appetite, Fatigue, Headache, Malaise, Muscular Weakness, Paraesthesia, Tension Headache
Adverse event was reported on Sep 09, 2010 by a Female patient taking Botox (View Usage) (Dosage: Unk) was diagnosed with skin wrinkling and. Location: UNITED KINGDOM , 48 years of age, Patient experienced the following unwanted or unexpected effects: burning sensation, decreased appetite, fatigue, headache (What is headache?), malaise, muscular weakness, paraesthesia, tension headache.

6984772-8 | Acute Disseminated Encephalomyelitis, Ataxia, Chills, Convulsion, Mental Status Changes, Pyrexia, Somnolence
on Sep 07, 2010 Male patient from UNITED STATES , 63 years of age, weighting 262.0 lb, was diagnosed with dystonia (What is dystonia?), hypertension, back pain (What is back pain?), dyslipidaemia, erectile dysfunction (What is erectile dysfunction?) and was treated with Botox (View Usage). Patient had the following side effects: acute disseminated encephalomyelitis, ataxia (What is ataxia?), chills, convulsion, mental status changes, pyrexia, somnolence. Botox dosage: 235 Units, Single. During the same period patient was treated with LISINOPRIL (20 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), CODEINE W/PARACETAMOL (30/300 Mg Prn) (View Codeine W/paracetamol Review and Codeine W/paracetamol Label ), NIACIN (500 Mg, Qhs) (View Niacin Review and Niacin Label ), SALSALATE (750 Mg, Bid) (View Salsalate Review and Salsalate Label ), VARDENAFIL HYDROCHLORIDE (LEVITRA) (10 Mg, 1 Hour Prior To Activity) (View Vardenafil Hydrochloride (levitra) Review and Vardenafil Hydrochloride (levitra) Label ). Patient was hospitalized.

6983948-3 | Dysarthria, Dysphagia, Dyspnoea, Muscular Weakness, Neuromyopathy, Pneumonia, Regurgitation, Respiratory Distress, Respiratory Failure
on Aug 31, 2010 Female patient from ITALY , 75 years of age, was diagnosed with oesophageal achalasia and was treated with Botox (View Usage). After Botox was administered, patient had the following side effects: dysarthria, dysphagia, dyspnoea, muscular weakness, neuromyopathy, pneumonia (What is pneumonia?), regurgitation, respiratory distress, respiratory failure. Botox dosage: Unk. Patient was hospitalized.

6979516-X | Dyspnoea, Formication, Immune System Disorder, Rash Pruritic, Viral Infection
Patient was taking Botox (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, formication, immune system disorder, rash pruritic, viral infection (What is viral infection?) on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 164.0 lb, was diagnosed with skin wrinkling and. Botox dosage: .

6978810-6 | Dysphagia, Dysphonia, Laryngitis, Muscular Weakness
Adverse event was reported on Sep 08, 2010 by a Female patient taking Botox (View Usage) (Dosage: 500 Units, Single) was diagnosed with paraparesis, muscle spasms, blood cholesterol increased, muscle spasticity and. Location: UNITED STATES , 56 years of age, weighting 160.0 lb, Patient had the following side effects: dysphagia, dysphonia, laryngitis, muscular weakness. During the same period patient was treated with LOVASTATIN (40 Mg, Qd) (View Lovastatin Review and Lovastatin Label ), BACLOFEN (20 Mg, Bid) (View Baclofen Review and Baclofen Label ).

6977038-3 | Muscle Spasms, Nausea, Oedema Peripheral
on Sep 03, 2010 Female patient from UNITED KINGDOM , 53 years of age, was diagnosed with anal fissure and was treated with Botox (View Usage). After Botox was administered, patient had the following side effects: muscle spasms, nausea (What is nausea?), oedema peripheral. Botox dosage: Unk. During the same period patient was treated with CHOLESTAGEL (Unk) (View Cholestagel Review and Cholestagel Label ), RANITIDINE (Unk) (View Ranitidine Review and Ranitidine Label ).

6973709-3 | Back Pain, Chest Pain
on Sep 03, 2010 Female patient from UNITED STATES , 56 years of age, was diagnosed with torticollis and was treated with Botox (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), chest pain (What is chest pain?). Botox dosage: 180 Units, Single. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6969572-7 | Dizziness, Headache, Nasal Disorder, Neck Pain, Unevaluable Event, Vision Blurred
Patient was taking Botox (View Usage). Patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), nasal disorder, neck pain, unevaluable event, vision blurred on Sep 07, 2010 from UNITED STATES Additional patient health information: Female patient , 31 years of age, weighting 146.0 lb, was diagnosed with skin cosmetic procedure and. Botox dosage: 28 Units Once. Patient was hospitalized.

6967495-0 | Aphasia, Apnoea, Cachexia, Pneumonia, Tracheomalacia
Adverse event was reported on Aug 25, 2010 by a Male patient taking Botox (View Usage) (Dosage: 200 Units, Single) was diagnosed with muscle spasticity, constipation (What is constipation?) and. Location: UNITED STATES , 19 years of age, After Botox was administered, patient had the following side effects: aphasia (What is aphasia?), apnoea, cachexia, pneumonia (What is pneumonia?), tracheomalacia. During the same period patient was treated with SINEMET (Unk) (View Sinemet Review and Sinemet Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), MIRALAX (15 Mg, Qd) (View Miralax Review and Miralax Label ). Patient was hospitalized.

6966189-5 | Asthenia, Confusional State, Encephalitis, Fatigue, Gait Disturbance, Incontinence, Nausea, Pyrexia
on Aug 31, 2010 Female patient from UNITED STATES , 60 years of age, was diagnosed with blepharospasm and was treated with Botox (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, confusional state, encephalitis (What is encephalitis?), fatigue, gait disturbance, incontinence, nausea (What is nausea?), pyrexia. Botox dosage: Unk. Patient was hospitalized.

6963784-4 | Grand Mal Convulsion
on Aug 31, 2010 Female patient from UNITED STATES , 17 years of age, was diagnosed with muscle spasticity and was treated with Botox (View Usage). Patient had the following side effects: grand mal convulsion. Botox dosage: 90 Units, Single. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), VALIUM (View Valium Review and Valium Label ), TIZANIDINE HCL (View Tizanidine Hcl Review and Tizanidine Hcl Label ).

6962848-9 | Organ Failure, Petechiae, Weight Decreased
Patient was taking Botox (View Usage). After Botox was administered, patient had the following side effects: organ failure, petechiae, weight decreased on Aug 25, 2010 from UNITED STATES Additional patient health information: Female patient , 32 years of age, was diagnosed with cerebral palsy and. Botox dosage: Unk. During the same period patient was treated with BACLOFEN (20 Mg, Qid) (View Baclofen Review and Baclofen Label ), ZANAFLEX (4 Mg, Tid) (View Zanaflex Review and Zanaflex Label ), CELEBREX (200 Mg, Qd) (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

6959358-1 | Acne, Depression, Injection Site Reaction
Adverse event was reported on Aug 31, 2010 by a Female patient taking Botox (View Usage) (Dosage: Just Once) was diagnosed with skin wrinkling and. Location: UNITED STATES , 34 years of age, weighting 125.0 lb, Patient experienced the following unwanted or unexpected effects: acne (What is acne?), depression (What is depression?), injection site reaction.

6959122-3 |
on Aug 25, 2010 Female patient from UNITED STATES , 29 years of age, was diagnosed with muscle spasticity and was treated with Botox (View Usage). . Botox dosage: 200 Units, Single.

6958346-9 | Stevens-johnson Syndrome
on Aug 26, 2010 Male patient from UNITED STATES , 74 years of age, was diagnosed with torticollis and was treated with Botox (View Usage). After Botox was administered, patient had the following side effects: stevens-johnson syndrome. Botox dosage: Unk.

6946304-X | Pregnancy, Premature Labour
Patient was taking Botox (View Usage). Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?), premature labour on Aug 24, 2010 from SOUTH AFRICA Additional patient health information: Female patient , 30 years of age, was diagnosed with hyperhidrosis and. Botox dosage: 105 Units, Single. Patient was hospitalized.

6946303-8 | Asphyxia, Aspiration
Adverse event was reported on Aug 25, 2010 by a Female patient taking Botox (View Usage) (Dosage: 150 Units, Single) was diagnosed with muscle spasticity, medical diet and. Location: SWITZERLAND , 53 years of age, Patient had the following side effects: asphyxia, aspiration. During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), ISOSOURCE (View Isosource Review and Isosource Label ), BONIVA (View Boniva Review and Boniva Label ).

6946302-6 | Dysphagia, Laryngitis, Muscular Weakness
on Aug 24, 2010 Female patient from UNITED STATES , 56 years of age, was diagnosed with muscle spasticity, muscle spasms and was treated with Botox (View Usage). After Botox was administered, patient had the following side effects: dysphagia, laryngitis, muscular weakness. Botox dosage: 100 Units, Single.

6939377-1 | Bone Density Decreased, Spinal Fracture
on Aug 19, 2010 Female patient from UNITED STATES , 56 years of age, was diagnosed with temporomandibular joint syndrome, muscle spasms and was treated with Botox (View Usage). Patient experienced the following unwanted or unexpected effects: bone density decreased, spinal fracture. Botox dosage: Unk.

6939217-0 | Alopecia, Back Pain, Burning Sensation, Bursitis, Cognitive Disorder, Confusional State, Dementia, Diarrhoea, Encephalitis
Patient was taking Botox (View Usage). Patient had the following side effects: alopecia, back pain (What is back pain?), burning sensation, bursitis (What is bursitis?), cognitive disorder, confusional state, dementia (What is dementia?), diarrhoea, encephalitis (What is encephalitis?) on Aug 18, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 137.0 lb, was diagnosed with torticollis, head titubation, tremor, pain (What is pain?) and. Botox dosage: 200 Units, Single. During the same period patient was treated with MYSOLINE (450 Mg, Unk) (View Mysoline Review and Mysoline Label ), DEPO MEDROL (20 Units, Single) (View Depo-medrol Review and Depo-medrol Label ). Patient was hospitalized and became disabled.

6937734-0 | Fatigue, Headache, Hypoaesthesia Oral, Nausea, Oropharyngeal Pain, Pyrexia
Adverse event was reported on Aug 20, 2010 by a Female patient taking Botox (View Usage) (Dosage: 28 Units Once On- Ongoing) was diagnosed with skin cosmetic procedure and. Location: UNITED STATES , 52 years of age, weighting 108.0 lb, After Botox was administered, patient had the following side effects: fatigue, headache (What is headache?), hypoaesthesia oral, nausea (What is nausea?), oropharyngeal pain, pyrexia.

6934267-2 |
on Aug 19, 2010 Female patient from SWITZERLAND , 53 years of age, was diagnosed with muscle spasticity and was treated with Botox (View Usage). . Botox dosage: 150 Units, Single.

6929862-0 | Anger, Incorrect Dose Administered, Unevaluable Event
on Aug 17, 2010 Female patient from UNITED STATES , weighting 128.0 lb, was treated with Botox (View Usage). Patient had the following side effects: anger, incorrect dose administered, unevaluable event. Botox dosage: .

6925121-0 | Splenomegaly
Patient was taking Botox (View Usage). After Botox was administered, patient had the following side effects: splenomegaly on Aug 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 47 years of age, was diagnosed with musculoskeletal pain and. Botox dosage: 65 Units, Single.

6925106-4 | Chest Discomfort, Pneumothorax
Adverse event was reported on Aug 09, 2010 by a Male patient taking Botox (View Usage) (Dosage: Unk) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 26 years of age, Patient experienced the following unwanted or unexpected effects: chest discomfort, pneumothorax.

6924484-X | Electrocardiogram St Segment Depression, Epilepsy
on Aug 06, 2010 Male patient from FRANCE , 67 years of age, weighting 132.3 lb, was diagnosed with muscle spasticity, arterial disorder, pain in extremity, depression (What is depression?), ischaemic stroke, carotid artery thrombosis, constipation (What is constipation?) and was treated with Botox (View Usage). Patient had the following side effects: electrocardiogram st segment depression, epilepsy (What is epilepsy?). Botox dosage: 125 Units, Single. During the same period patient was treated with BUFLOMEDIL (600 Mg, Qd (150 Mg X 4)) (View Buflomedil Review and Buflomedil Label ), ZAMUDOL (400 Unk, Qd (200lp X2)) (View Zamudol Review and Zamudol Label ), STABLON (25 Mg, Qd (12.5 Mgx2)) (View Stablon Review and Stablon Label ), OGASTORO (15 Mg, Qd) (View Ogastoro Review and Ogastoro Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), FORLAX (2df Daily) (View Forlax Review and Forlax Label ). Patient was hospitalized.

6922873-0 | Acute Disseminated Encephalomyelitis, Ataxia, Chills, Mental Status Changes, Pyrexia, Somnolence, Urinary Incontinence
on Aug 03, 2010 Male patient from UNITED STATES , 63 years of age, weighting 262.0 lb, was diagnosed with dystonia (What is dystonia?), hypertension, back pain (What is back pain?), dyslipidaemia, erectile dysfunction (What is erectile dysfunction?) and was treated with Botox (View Usage). After Botox was administered, patient had the following side effects: acute disseminated encephalomyelitis, ataxia (What is ataxia?), chills, mental status changes, pyrexia, somnolence, urinary incontinence (What is urinary incontinence?). Botox dosage: 235 Units, Single. During the same period patient was treated with LISINOPRIL (20 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), CODEINE W/PARACETAMOL (30/300 Mg Prn) (View Codeine W/paracetamol Review and Codeine W/paracetamol Label ), NIACIN (500 Mg, Qhs) (View Niacin Review and Niacin Label ), SALSALATE (750 Mg, Bid) (View Salsalate Review and Salsalate Label ), VARDENAFIL HYDROCHLORIDE (LEVITRA) (10 Mg, 1 Hour Prior To Activity) (View Vardenafil Hydrochloride (levitra) Review and Vardenafil Hydrochloride (levitra) Label ). Patient was hospitalized.

6922113-2 | Dysphagia, Dyspnoea, Pneumonia Aspiration
Patient was taking Botox (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, dyspnoea, pneumonia aspiration on Aug 05, 2010 from CANADA Additional patient health information: Female patient , 75 years of age, . Botox dosage: Unk.

6922073-4 | Amnesia, Asphyxia, Choking, Dysphonia, Dyspnoea, Facial Paresis, Jaw Disorder, Laryngospasm, Loss Of Consciousness
Adverse event was reported on Aug 05, 2010 by a Female patient taking Botox (View Usage) (Dosage: Unk) . Location: CANADA , 41 years of age, weighting 149.0 lb, Patient had the following side effects: amnesia, asphyxia, choking (What is choking?), dysphonia, dyspnoea, facial paresis, jaw disorder, laryngospasm, loss of consciousness. During the same period patient was treated with FIORINAL (View Fiorinal Review and Fiorinal Label ), FLOVENT (View Flovent Review and Flovent Label ), LOMINE (View Lomine Review and Lomine Label ), MAXALT MLT (View Maxalt-mlt Review and Maxalt-mlt Label ), NASONEX (View Nasonex Review and Nasonex Label ), PMS ERYTHROMYCIN OPHTHALMIC (View Pms Erythromycin Ophthalmic Review and Pms Erythromycin Ophthalmic Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), REACTINE (View Reactine Review and Reactine Label ). Patient was hospitalized and became disabled.

6922071-0 | Brain Injury, Convulsion, Ear Infection, Heart Rate Decreased, Hypotonia, Lethargy, Liver Function Test Abnormal
on Aug 05, 2010 Male patient from UNITED STATES , child 4 years of age, weighting 39.99 lb, was diagnosed with muscle spasticity, muscle contracture and was treated with Botox (View Usage). After Botox was administered, patient had the following side effects: brain injury, convulsion, ear infection (What is ear infection?), heart rate decreased, hypotonia, lethargy, liver function test abnormal. Botox dosage: 200 Units, Single. During the same period patient was treated with EMLA (View Emla Review and Emla Label ), FLUNISOLIDE (View Flunisolide Review and Flunisolide Label ), L CARNITINE (View L-carnitine Review and L-carnitine Label ).

6922042-4 | Bronchopneumonia
on Aug 05, 2010 Female patient from CANADA , 56 years of age, weighting 99.21 lb, was treated with Botox (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopneumonia. Botox dosage: 100 Units, Single. During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), CALCIUM (View Calcium Review and Calcium Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LITHANE (View Lithane Review and Lithane Label ), NITRAZADON (View Nitrazadon Review and Nitrazadon Label ).

6922041-2 | Ageusia, Anosmia, Asthenia, Blister, Burning Sensation, Chest Pain, Chills, Condition Aggravated, Diplopia
Patient was taking Botox (View Usage). Patient had the following side effects: ageusia, anosmia, asthenia, blister, burning sensation, chest pain (What is chest pain?), chills, condition aggravated, diplopia on Aug 05, 2010 from CANADA Additional patient health information: Female patient , 50 years of age, . Botox dosage: 500 Units, Single.

6922040-0 | Abdominal Distension, Cardiac Arrest, Dysphagia, Dyspnoea, Hyponatraemia, Intestinal Ischaemia, Multi-organ Failure, Pneumonia Aspiration, Pyrexia
Adverse event was reported on Aug 05, 2010 by a Female patient taking Botox (View Usage) (Dosage: 200 Units, Single) . Location: CANADA , 81 years of age, weighting 116.8 lb, After Botox was administered, patient had the following side effects: abdominal distension, cardiac arrest (What is cardiac arrest?), dysphagia, dyspnoea, hyponatraemia, intestinal ischaemia, multi-organ failure, pneumonia aspiration, pyrexia. During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), APO PRIMIDONE (View Apo-primidone Review and Apo-primidone Label ), INDERAL LA (View Inderal La Review and Inderal La Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), WARFARIN (View Warfarin Review and Warfarin Label ). Patient was hospitalized.

6920844-1 | Dysphagia, Facial Paresis, Mastication Disorder, Photophobia, Speech Disorder, Strabismus, Viith Nerve Paralysis, Visual Impairment, Weight Decreased
on Aug 05, 2010 Female patient from CANADA , 49 years of age, was treated with Botox (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, facial paresis, mastication disorder, photophobia, speech disorder, strabismus, viith nerve paralysis, visual impairment, weight decreased. Botox dosage: 100 Units, Single. During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), DIOVAN (View Diovan Review and Diovan Label ), ELMIRON (View Elmiron Review and Elmiron Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), RHOVANE (View Rhovane Review and Rhovane Label ).

6920842-8 | Asthenia, Hypoaesthesia, Multiple Sclerosis Relapse, Peroneal Nerve Palsy
on Aug 05, 2010 Female patient from CANADA , 37 years of age, weighting 103.6 lb, was treated with Botox (View Usage). Patient had the following side effects: asthenia, hypoaesthesia, multiple sclerosis relapse, peroneal nerve palsy. Botox dosage: Unk. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ).

6920841-6 | Depression, Dry Mouth, Hypokinesia, Lethargy, Muscular Weakness, Paraesthesia, Speech Disorder
Patient was taking Botox (View Usage). After Botox was administered, patient had the following side effects: depression (What is depression?), dry mouth, hypokinesia, lethargy, muscular weakness, paraesthesia, speech disorder on Aug 05, 2010 from CANADA Additional patient health information: Male patient , 64 years of age, weighting 148.0 lb, . Botox dosage: 300 Units, Single. During the same period patient was treated with ALTACE (View Altace Review and Altace Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), COSOPT (View Cosopt Review and Cosopt Label ), FLOMAX (View Flomax Review and Flomax Label ), LIPITOR (View Lipitor Review and Lipitor Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6920837-4 | Choking, Dysphagia, Motor Dysfunction, Muscular Weakness, Tremor
Adverse event was reported on Aug 05, 2010 by a Male patient taking Botox (View Usage) (Dosage: 18 Units, Single) . Location: CANADA , 72 years of age, Patient experienced the following unwanted or unexpected effects: choking (What is choking?), dysphagia, motor dysfunction, muscular weakness, tremor. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), FLOMAX (View Flomax Review and Flomax Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), SELENIUM (View Selenium Review and Selenium Label ), WARFARIN (View Warfarin Review and Warfarin Label ).

6920836-2 | Dyspnoea, Pulmonary Embolism
on Aug 05, 2010 Male patient from CANADA , 62 years of age, weighting 290.0 lb, was treated with Botox (View Usage). Patient had the following side effects: dyspnoea, pulmonary embolism (What is pulmonary embolism?). Botox dosage: 7.5 Units, Single. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6920225-0 | Alopecia, Back Pain, Burning Sensation, Bursitis, Cognitive Disorder, Confusional State, Dementia, Diarrhoea, Encephalitis
on Aug 03, 2010 Female patient from UNITED STATES , 56 years of age, weighting 137.0 lb, was diagnosed with torticollis, head titubation, tremor, pain (What is pain?) and was treated with Botox (View Usage). After Botox was administered, patient had the following side effects: alopecia, back pain (What is back pain?), burning sensation, bursitis (What is bursitis?), cognitive disorder, confusional state, dementia (What is dementia?), diarrhoea, encephalitis (What is encephalitis?). Botox dosage: 200 Units, Single. During the same period patient was treated with MYSOLINE (450 Mg, Unk) (View Mysoline Review and Mysoline Label ), DEPO MEDROL (20 Units, Single) (View Depo-medrol Review and Depo-medrol Label ). Patient was hospitalized and became disabled.

6918805-1 | Asthenia, Balance Disorder, Condition Aggravated, Drooling, Dysphagia, Mastication Disorder
Patient was taking Botox (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, balance disorder, condition aggravated, drooling, dysphagia, mastication disorder on Aug 05, 2010 from CANADA Additional patient health information: Female patient , child 4 years of age, weighting 37.48 lb, . Botox dosage: 300 Units, Single. During the same period patient was treated with POLYETHYLENE GLYCOL (View Polyethylene Glycol Review and Polyethylene Glycol Label ). Patient was hospitalized.

6918787-2 | Dysphagia
Adverse event was reported on Aug 04, 2010 by a Male patient taking Botox (View Usage) (Dosage: 12.5 Units, Single) was diagnosed with oromandibular dystonia and. Location: UNITED STATES , 26 years of age, Patient had the following side effects: dysphagia.

6917315-5 | Fatigue, Mobility Decreased, Muscular Weakness
on Aug 05, 2010 Female patient from CANADA , 27 years of age, weighting 99.98 lb, was treated with Botox (View Usage). After Botox was administered, patient had the following side effects: fatigue, mobility decreased, muscular weakness. Botox dosage: 400 Units, Single.

6916915-6 | Saliva Altered
on Aug 05, 2010 Female patient from CANADA , 60 years of age, weighting 143.3 lb, was treated with Botox (View Usage). Patient experienced the following unwanted or unexpected effects: saliva altered. Botox dosage: 40 Units, Single. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM (View Calcium Review and Calcium Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), LECITHIN (View Lecithin Review and Lecithin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PREMARIN (View Premarin Review and Premarin Label ).

6916226-9 | Muscular Weakness, Therapeutic Agent Toxicity
Patient was taking Botox (View Usage). Patient had the following side effects: muscular weakness, therapeutic agent toxicity on Aug 05, 2010 from CANADA Additional patient health information: Female patient , 40 years of age, . Botox dosage: 550 Units, Single. During the same period patient was treated with ORAL CONTRACEPTIVE NOS (View Oral Contraceptive Nos Review and Oral Contraceptive Nos Label ).